The differential effects produced by cis- and trans-DDP on DNA in calf thymus nucleosomes  by Simpkins, H. & Pearlman, L.F.
Volume 169, number 1 FEBS 1339 April 1984 
The differential effects produced by cis- and tracts-DDP on 
DNA in calf thymus nucleosomes 
H. Simpkins and L.F. Pearlman 
Departments of Pathology and Biological Chemistry, University of California, Irvine, CA, USA 
Received 6 February 1984 
Calf thymus nucleosomes containing Hl were treated with dichlorodiammineplatinum (DDP) at low 
binding ratios (r = 0.05-0.15). Change in the electrophoretic mobility of the extracted nucleosomal DNA 
was observed following treatment with cis-DDP and little change with trans-DDP. There was a decrease 
in the electrophoretic mobility of the nucleosomal DNA as well as obliteration of the nucleosomal repeat 
distance. The fluorescence intensity of terbium binding to the extracted DNA showed minimal change 
following drug treatment. However, the thermal melting behavior of the nucleosomal DNA was altered 
to a greater extent following cis-DDP treatment at 280 rather than 260 nm and a destabilization of the 
DNA helix was observed. These data suggest hat in the whole nucleosome, cis-DDP produces greater 




cis-Dichlorodiammineplatinum (cis-DDP) is a 
potent anti-tumor drug now in use clinically to 
treat head, neck and testicular cancer and recently 
lymphoma. The trans isomer possesses little to no 
anti-tumor activity. DNA is thought to be the 
prime target for cis-DDP [ 1,2]. The ensuing lesion 
which presumably inhibits DNA synthesis is 
thought to be either interstrand [3,4] or intrastrand 
crosslinks [5]. However, the DNA in eukaryotic 
cells is associated with histone and non-histone 
proteins and, thus, the possibility of DNA-protein 
crosslinks must also be considered [6]. trans-DDP 
has also been shown to produce crosslinks, 
although this isomer is thought to be more effec- 
tive in producing protein-protein and protein- 
DNA crosslinks than cis-DDP [7]. The trans 
isomer does produce DNA crosslinks as well, but 
much more slowly and at higher drug concentra- 
tions than does cis-DDP. Limited reports have ap- 
peared studying the effect of these drugs on 
chromatin or nucleosomes. The first such in- 
vestigation in [7] employed nucleosome core par- 
DNA melting profile 
titles and showed the formation of DNA-protein 
as well as protein-protein crosslinks. We have 
employed fluorescent probes [8], and showed that 
at very low drug concentrations both cis- and 
trans-DDP produce effects on the histone proteins 
in calf thymus nucleosomes. We have extended our 
work to show that nucleosomal DNA, extracted 
from drug-treated nucleosomes, possesses differ- 
ing electrophoretic mobilities and exhibits dif- 
ferent melting behavior to DNA extracted from 
non-treated nucleosomes. The results are similar to 
those recently reported studying the effect of cis- 
DDP on isolated supercoiled SV40 DNA [9] as well 
as earlier experiments employing pSM1 DNA [lo] 
and PM2 supercoiled DNA [ 111, which report 
retardation of the cis-DDP-treated supercoiled 
DNA on agarose gels at far shorter incubation 
times and/or concentrations than those required 
with the trans isomer. 
2. MATERIALS AND METHODS 
cis-Dichlorodiammineplatinum(I1) was pur- 
chased from Aldrich. trans-Dichlorodiammine- 
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platinum(I1) was synthesized from potassium 
tetrachloroplatinate as in [ 121. Nucleosomes were 
prepared from calf thymus using a modification of 
the procedure in [13]. Five g of calf thymus were 
homogenized in buffer A [0.25 M sucrose, IO mM 
MgCL, 1 mM CaC12, 1 mM phenylmethylsulfonyl 
fluoride (PMSF), 0.1% Triton X-100, 50 mM 
Tris-HCI (pH 7.4)] and then washed 3 times in 
buffer A without Triton X-100. The nuclei were 
suspended in buffer B [lo mM Tris-HCI (pH 7.5), 
10 mM NaCI, 3 mM MgClz, 1 mM PMSF] con- 
taining 1 mM CaC12, washed twice and digested 
for 30 min with micrococcal nuclease (P-L Bio- 
chemicals, 25 units/ml), at a DNA concentration 
of approx. 10 mg/ml. The reaction was terminated 
by chilling the tubes and centrifuging for 5 min at 
4000 x g in a Sorvall HB4 rotor. The pellet was 
resuspended with a Dounce homogenizer in buffer 
C [l mM EDTA, 10 mM Tris-HCI (pH 7.5), 
1 mM PMSF], swelled on ice for 20 min and then 
centrifuged for 20 min at 16000 x g. This last step 
was repeated with the resulting pellet and the two 
supernatants were combined. The nucleosomes 
were recovered by adding 0.1 M NaCl and 3 vols 
ethanol at - 20°C. This is the procedure described 
by authors in [ 131, employed to fractionate active 
nucleosomes from trout testes and then employed 
with calf thymus nuclei to produce a fraction of 
mono-, di- and trinucleosomes containing HI. We 
have also used this technique with rat liver and calf 
thymus to produce HI containing mono- and 
dinucleosome fractions which were characterized 
by sucrose gradient centrifugation, SDS-polyacryl- 
amide gel and agarose gel electrophoresis to pro- 
duce particles primarily of approx. 200 bp average 
repeat distance and containing Hl [14]. The 
nucleosomes were then resuspended into 10 mM 
sodium phosphate (pH 6), containing 1 mM 
NazEDTA, 1 mM PMSF and 5 mM NaCl. The 
protein concentration was determined as in [15] 
employing a calf thymus histone solution as a stan- 
dard. Nucleosomes were incubated with either cis- 
or truns-DDP for differing lengths of time (0.5- 
2 h). Control mononucleosomes were incubated in 
parallel, substituting buffer for drug. The drug 
concentrations varied from 0.03 to 0.3 mM DDP 
with 0.25 mg/ml of nucleosomal protein. The 
reactions were quenched and the nucleosomes 
recovered by adding concentrated NaCl to raise the 
chloride concentration to 0.2 M and 3 vols ethanol 
at -20°C. 
Proteins were determined as in [15] employing a 
calf thymus histone solution as a standard. DNA 
was extracted from a portion of the drug-treated 
nucleosomes by addition of 400~1 trypsin 
(1 mg/ml) to 2 ml nucleosome suspension (0.6 mg 
DNA/ml), and the mixture incubated at 37°C for 
60 min. A lo-fold excess of fresh chloroform- 
isoamyl alcohol (24: 1) was added, vortex mixed 
and allowed to stand at room temperature before 
being centrifuged at 1000 x g for 10 min. The 
aqueous layer was removed and the DNA preci- 
pitated by the addition of 0.2 M NaCl and 3 vols 
of ethanol at -20°C. 
Agarose gel electrophoresis was performed as in 
[ 161 and stained with 1 ,ug/ml of ethidium bromide 
for 30 min followed by destaining in water over- 
night at 4°C. The histone proteins were monitored 
by SDS-polyacrylamide gel electrophoresis using a 
modification of the procedure in [ 171. The stacking 
gel contained 4.2% (w/v) acrylamide-bisacryl- 
amide (37.5: 1, w/w) in 0.1% SDS, 0.125 M 
Tris-HCl (pH 6.8). The separating gel contained 
12% (w/v) acrylamide-bisacrylamide (37.5 : 1, 
w/w) in 0.1% SDS, 0.375 M Tris-HCl (pH 8.8) 
and the reservoir buffer contained 0.1% SDS, 
0.19 M glycine, 0.015 M Tris-HCI (pH 8.2). The 
current was maintained at 7.5 mA until the sam- 
ples had migrated through the separating el when 
it was increased to 12.5 mA until the marker dye 
was within 0.5 cm of the bottom. The gels were 
stained with 0.1% (w/v) Coomassie blue in 
methanol-acetic acid-water (10 : 7 : 83, v/v) and 
destained in the same solvent mixture. Melting 
curves were performed in a Gilford 250 spectro- 
photometer with quartz cuvettes. The temperature 
was increased at l”C/min from 25 to 90°C by a 
circulating water bath. Terbium binding curves 
were performed with the extracted DNA at a cons- 
tant concentration of nucleic acid-P (50,~M) with 
increasing terbium concentrations (O-200 PM). 
The buffer employed was 20 mM Tris-HCl (pH 
7.3). An excitation wavelength of 290 nm was used 
with an emission wavelength of 544 nm in a Perkin 
Elmer 43A fluorescence spectrophotometer. Plati- 
num determinations were performed using an 
IL151 flame photometer equipped with a platinum 
lamp. The samples were digested in 0.1 N HCI 
prior to their nucleotide concentration being deter- 
mined at 260 nm and the platinum concentration 
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Table 1 
Binding of cis- and trans-DDP to calf thymus nucleosomes 
Concentration of Time of incubation Concentration of Concentration of
DDP added (uM) (min) bound cis-DDP/ bound trans-DDP/ 
pM DNA (r) PM DNA (r) 
0.3 120 0.14 + 0.03 0.14 + 0.03 
0.075 30 0.07 + 0.02 0.09 + 0.02 
0.03 30 0.03 f 0.01 0.04 & 0.02 
Experimental conditions and nucleotide and platinum determinations were 
determined as described inthe text. The nucleosome concentration was constant 
at 0.25 mg/ml of nucleosomal protein. The error is expressed as + SE 
compared to a standard curve employing a solu- 
tion of K2PtCld in 0.1 N HCl. 
3. RESULTS AND DISCUSSION 
In table 1 is presented the amount of platinum 
bound/PM DNA-P at different drug concentra- 
tions and incubation times with calf thymus 
nucleosomes. It can be seen that at the lowest con- 
centration and shortest incubation time an r value 
of approx. 0.05 is observed, which increases to ap- 
prox. 0.15 at the highest drug concentration and 
longest incubation time employed. These r values 
are higher than those with kidney nucleosomal 
core particles labelled with radioactive DDP 
reported in [7]. 
When the DNA is extracted from the treated 
nucleosomes and subsequently analyzed on 
agarose gels, a retardation in mobility as well as a 
diminution in fluorescence intensity is observed in 
the fluorescence of the ethidium bromide stain 
with the cis-DDP-treated nucleosomal DNA (see 
fig.1). The effect is evident only at the high drug 
concentration and long incubation time (cor- 
responds to r = 0.15). The retardation produced by 
the cis-DDP is greater than any effect observed 
& bed et 
Fig. 1. Agarose gels (1.5%) of control nucleosomal DNA (a), DNA from cis-DDP-treated nucleosomes (b), DNA from 
nucleosomes treated with tram-DDP (c) and the experiment repeated (d) control, (e) cis-DDP- and (f) trans-DDP- 
treated nucleosomes. Experimental conditions are described in the text and the nucleosomal DNA concentration was 
equal in each lane (4 pg, lanes a-f). M, markers of HindIII-digested ADNA (g) and 4X174 DNA (h) are presented. In 
addition, from another experiment, pBR322 DNA treated with a similar concentration of cis-DDP (i) and trans-DDP 
(j) is presented. (k) Control, non-treated pBR322 DNA. 
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with trans-DDP and is similar to the effect observ- 
ed with pBR322 DNA incubated with cis-DDP 
(although quantitatively smaller). Authors in [9] 
reported a diminution in the mobility of SV40 
DNA which they ascribed to an unwinding of the 
DNA. They showed that the effect produced by 
cis-DDP becomes apparent at a binding ratio of 
approx. 0.08 and with trans-DDP at a binding 
ratio of 0.15. Thus, the effect is observed at far 
lower amounts of bound drug with supercoiled 
DNA. It must, however, be pointed out that with 
supercoiled DNA, a decrease in mobility of form 
I is directly correlated to its unwinding. Changes in 
the electrophoretic mobility of linear DNA cannot 
be explained as easily since unwinding may pro- 
duce an increase in mobility whereas the formation 
of higher M, species, by crosslinking, etc., could 
result in decreased mobility. However, we have 
shown [ 181 that polydisperse linear DNAs are 
retarded following treatment with cis-DDP and 
that the ethidium bromide fluorescence is 
diminished whereas that of acridine orange ex- 
hibits a red shift suggesting unwinding of the helix. 
This effect with linear DNA, however, was not as 
dramatic as that observed with supercoiled DNA. 
In addition, we have shown that linear DNA 
treated with cis- and trans-DDP [18] results in the 
helix being disrupted by the former but not the lat- 
ter, and ‘opened-up’ regions and/or nicks are pro- 
duced so that the DNA becomes more accessible to 
terbium (a fluorescent probe specific for unpaired 
guanine residues [19,20]). Thus, it was of interest 
to determine whether this effect was observed with 
DNA isolated from calf thymus nucleosomes 
which had been treated with these drugs. The ex- 
tracted DNA was reacted with terbium - no 
significant enhancement in fluorescence intensity 
was observed. The IO-fold enhancement observed 
following cis-DDP treatment of linear DNA 
(defined Hind111 restriction enzyme fragments and 
polydisperse calf thymus or E. cofi DNA) was not 
observed with DNA isolated from treated 
nucleosomes [181. 
Finally, the nucleosomal DNA was analyzed by 
its melting behavior at 260 nm (which primarily 
reflects A-T rich regions), and at 280 nm (which 
reflects G-C rich regions) (see fig.2). It was found 
that a marked decrease in melting temperature as 
well as a broadening of the melting curves was 
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Fig.2. Melting curves performed at 280 nm (A) of DNA 
extracted from control calf thymus nucleosomes (- - -), 
cis-DDP-treated nucleosomes (M) and fruns-DDP 
treated nucleosomes (o-a). Melting curves performed 
at 260 nm (B) of DNA extracted from control calf 
thymus nucleosomes (- - -), cis-DDP-treated nucleo- 
somes (ti) and trans-DDP-treated nucleosomes 
(D-O). The r value was 0.15. The solvent was 10 mM 
Na phosphate (pH 6.0) containing 1 mM PMSF and 
1 mM Na2EDTA. 
this effect was apparent even at lower r values 
(0.09-0.11) than those required to produce a 
change in electrophoretic mobility. In addition, the 
effect on melting behavior was more apparent at 
280 nm than at 260 nm, a result which correlates 
with the G-C specificity of cis-DDP with isolated 
linear DNA. No effect was observed at the lowest 
r value (0.05) in melting behavior or elec- 
trophoretic mobility, although at this level of drug 
binding changes were observed in the fluorescence 
intensity of a probe attached to histone H3 [8]. It 
should be pointed out that melting curves per- 
formed with drug-treated whole nucleosomes were 
frequently found to result in precipitation and thus 
were suspect. Also, the changes observed with ex- 
tracted DNA in 10 mM Na+ were also observed at 
lower ionic strengths (0.5 mM Na+). 
33 
Volume 169, number 1 FEBS LETTERS April 1984 
Our results involve employment of DNA ex- 
tracted from the drug-treated nucleosome for two 
reasons. Firstly, terbium titration curves as well as 
melting curves are suspect when performed with 
drug-treated nucleosomes due to precipitation pro- 
blems; secondly, any effects observed with the 
whole nucleosome can be due to changes within the 
DNA itself or an effect resulting from an altered 
DNA-protein interaction. Since it has been shown 
[7,8] that both drugs react with the nuclear pro- 
teins within the nucleosome, it appeared important 
to be able to separate this effect from that involv- 
ing solely the nucleosomal DNA. It is interesting to 
note that our data with DNA extracted from calf 
thymus nucleosomes parallel those observed with 
high M; chromatin threads [211. 
It can be argued that these results with drug- 
treated nucleosomes cannot be related to super- 
coiled plasmid DNA since the latter is under tor- 
sional stress and that relaxation of that stress is 
normally due to a change in the linking number 
(resulting in decreased electrophoretic mobility). 
However, recent evidence suggests that a small 
proportion of nucleosomal DNA may also be 
under torsional stress; (a) a small proportion of 
SV40 minichromatin can be relaxed with topoiso- 
merase I [22]; (b) authors in 1231 recently showed 
that the nuclease hypersensitive domains of globin 
gene DNA exist in supercoiled but not relaxed 
plasmid clones in positions corresponding to those 
activated in chromatin. It thus seems possible (as 
pointed out in a recent review [24]) that if a struc- 
tural change takes place in the nucleosome such as 
the rearrangement of a histone protein then the 
nucleosomal DNA at that site may be left under 
torsional strain. Since we [25] and others [26] have 
shown that cis-DDP interacts with histone and 
non-histone proteins, it is possible that the DNA at 
the site of interaction may be forced into the super- 
coiled state. However, these changes may involve 
only a small percentage of the total DNA, depen- 
ding on the number of drug binding sites and the 
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